Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acute Effects of E-Cigarette Aerosol Inhalation
NCT03479203Phase 1Completed
- Sponsor
- University of Pennsylvania
- Start
- May 2018
- Primary completion
- Aug 2022
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial, sponsored by University of Pennsylvania. Primary endpoints: Inflammatory Blood-Based Biomarkers at 120 months, Acute Change in Aortic Pulse Wave Velocity Post-vaping at 15 months and 5 more. Started May 2018; status: completed.
Beyond the preview
Go deeper on NCT03479203.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03479203.